MedTrace Logo

Effect of Blood Flow Restriction on Cardiovascular Function in Elderly with Metabolic Syndrome X

NCT06877130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-03-14

No results posted yet for this study

Summary

The purpose of the study is to investigate the effect of aerobic exercise with Blood flow restriction training (BFR) on cardiovascular function and quality of life in hypertensive elderly patients.

Hypothesis There will be no significant effect of aerobic exercise with RBF on cardiovascular function and the quality of life in hypertensive elderly patients.

Conditions

  • Metabolic Syndrome X
  • Cardiovascular Problems in Elderly

Interventions

OTHER

Aerobic exercise with BFR

To prescribe BFR training, Systolic blood pressure (SBP) will be measured using an automated oscillometer BP device. Blood pressure will be measured according to the recommendations of the American Heart Association. A bilateral restriction of 50% of the measured SBP will be applied to each lower limb for the application of BFR of lower limbs using the equipment. A wide cuff (18 cm wide) will be placed in the proximal portion of the thigh (inguinal fold region) and will be inflated until the absence of the tibial artery blood pulse. Thus, a 50% restriction of SBP will be applied in both legs during lower body exercises.

OTHER

Aerobic training

HR max = 206.9 - (0.67 x age). Moderate intensity aerobic exercise: the rate of heart reaches 64-76 percent of their age predicted peak hearty rate

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Zeinab Mohamed Helmy, Professor of Physical Therapy · Professor of Physical Therapy for Cardiovascular / Respiratory Disorders and Geriatrics Faculty of Physical Therapy Cairo University

  • Ebtesam Nabil Abdel Mohsen, Lecturer of Physical Therapy · Lecturer of Physical Therapy for Cardiovascular / Respiratory Disorders and Geriatrics Faculty of Physical Therapy Cairo University

  • Yasser Abdel Monem Elhendy, Professor of Internal Medicine · Professor of Internal Medicine Faculty of Medicine Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-01
Completion
2025-02-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06877130 on ClinicalTrials.gov